The PURE Study Tracked 101,945 People Across 17 Countries. The AHA Saw the Results and Kept Its Guidelines Anyway.

The PURE study (Prospective Urban Rural Epidemiology) tracked 101,945 people across 17 countries for a median of 3.7 years and found that those consuming the least sodium had the highest cardiovascular mortality. The findings were published in the New England Journal of Medicine in 2014. The AHA acknowledged them. The AHA recommendation of below 2.3 grams of sodium per day did not change.

That recommendation falls below the intake level, the largest cardiovascular nutrition study ever conducted, associated with increased risk of death from heart disease. The restriction was based on rat studies and population data assembled by researchers with documented financial relationships with the food industry. The independent data came in. The guidelines held.

The Study the AHA Acknowledged and Then Set Aside

Andrew Mente and Martin O'Donnell, researchers at the Population Health Research Institute at McMaster University in Hamilton, Canada, led the PURE sodium analysis. Rather than relying on dietary recall, which requires people to accurately remember and report everything they eat, the PURE team measured 24-hour urinary sodium excretion, a direct biomarker of how much sodium the body actually processes. Dietary recall systematically underestimates actual intake. Urinary measurement does not carry that error.

The finding was a J-curve. People consuming below 3 grams of sodium per day had a 27% higher risk of cardiovascular events compared to those consuming 4 to 6 grams per day. People consuming more than 7 grams per day also had an elevated risk compared with the moderate range. The safest zone, according to the PURE data, ran from 3 to 6 grams daily. The lower end of the intake was not protective. It was associated with harm.

The New England Journal of Medicine published the study in 2014. AHA-affiliated researchers subsequently published a methodological critique focused on the use of spot urine sampling in some PURE participants rather than full 24-hour collections. The PURE investigators responded with data showing their findings held under both methods. The AHA recommendation remained below 2.3 grams.

The Cochrane Collaboration reviewed the evidence on salt reduction and cardiovascular disease prevention in 2014. Its conclusion: reduced sodium intake lowers blood pressure in hypertensive and normotensive individuals, but clear evidence that it reduces cardiovascular events or mortality was not established across the available trials (Adler AJ, et al. Cochrane Database of Systematic Reviews. 2014;12:CD009217). Blood pressure reduction and cardiovascular mortality reduction are correlated outcomes but not equivalent ones. The AHA recommendation rests heavily on blood pressure as a surrogate endpoint. PURE measured actual events and deaths. Those are different things, and the discrepancy between them is documented and unresolved.

(Evidence level: 4. PURE is the largest prospective study of sodium intake and cardiovascular mortality using biomarker measurement. A single study does not override the full prior evidence base, but its findings cannot be dismissed without engaging its methodology directly.)

What Sodium Actually Does in the Body

Sodium is not an industrial contaminant. It is an essential electrolyte the body cannot manufacture. Every nerve impulse in the human body depends on the movement of sodium ions across cell membranes. Every muscle contraction, including every heartbeat, requires it. The kidneys regulate sodium through feedback loops involving aldosterone, renin, and antidiuretic hormone. When sodium intake drops, those systems activate to retain what the body cannot replace on its own.

The sodium-potassium pump runs in every cell membrane. It actively moves sodium out and potassium in, maintaining the electrical gradient that keeps cells functional. That gradient degrades without adequate sodium. The adrenal glands release aldosterone in response to low sodium, which increases water retention and drives up blood pressure through a different mechanism than the one sodium restriction is supposed to prevent. Chronic sodium restriction below physiological need does not simply lower blood pressure. It activates compensatory systems that can raise it through alternative pathways.

Sodium governs fluid balance in the bloodstream and in cells. Plasma volume depends on it. People who exercise, work outdoors in heat, or eat low-carbohydrate diets lose sodium at higher rates through sweat and reduced renal reabsorption. Their optimal intake differs from a sedentary person eating processed food in an air-conditioned office. The guidelines treat these populations as equivalent.

(Evidence level: 5 for sodium's essential physiological role. Established biochemistry, not contested.)

Where the Low-Sodium Guidelines Actually Came From

The institutional case for sodium restriction traces to Lewis Dahl, a researcher at Brookhaven National Laboratory whose 1972 rodent studies showed that high sodium intake caused hypertension. The dose in Dahl's rat studies equated to a human consuming approximately 500 grams of salt per day. The average American consumes roughly 3.4 grams. The jump from a rat consuming 50 times the typical human sodium load to a population-wide restriction recommendation was never supported by a rigorous dose-response analysis in humans.

The INTERSALT study of 1988 added population-level observational data. Researchers compared sodium excretion to blood pressure across 52 populations in 32 countries and found a positive association. The association was driven substantially by comparisons between extreme outlier populations, including groups with very low sodium intake and very low blood pressure, whose diets differed from those of high-sodium comparison populations in nearly every dimension: potassium intake, overall diet quality, caloric intake, and exposure to industrial foods. When those outlier populations were removed from the analysis, the sodium-blood pressure association weakened substantially. Critics of INTERSALT raised this issue at the time of publication. It did not change the direction of the guidelines.

The Dietary Guidelines Advisory Committee, which produces the federal dietary guidance that informs AHA recommendations, has included members with disclosed financial relationships to food companies, including Campbell Soup Company, which makes soup and has a direct commercial interest in sodium policy, and to pharmaceutical manufacturers whose products are prescribed more widely when more of the population is defined as requiring blood pressure management. These relationships are disclosed in committee financial disclosure forms. They are not hidden. They are also not discussed when the guidelines are presented to the public as an independent scientific consensus.

(Evidence level: 3 for the causal claim that restricting sodium reduces cardiovascular mortality in the general healthy population. The blood pressure reduction link is Level 4. The blood pressure-to-mortality translation is weaker than the guidelines imply.)

Why the Advice Applies Differently to Whole Food Eaters

The sodium problem in the American diet is not sodium in isolation. It is sodium without the potassium and magnesium that accompany it in whole food sources.

Processed food delivers high sodium alongside almost no potassium, minimal magnesium, and no fiber. One serving of canned soup can contain 900mg of sodium with essentially zero potassium. The foods that naturally contain sodium, animal products, seafood, and dairy, also naturally contain potassium, magnesium, and the mineral matrix the body expects to process alongside sodium.

Research by Frank Sacks at Harvard and by PURE investigators found that the sodium-to-potassium ratio predicted cardiovascular outcomes more reliably than sodium alone. A high sodium-to-potassium ratio, which is characteristic of processed foods, is associated with worse outcomes. A lower ratio, achieved by eating more potassium-rich vegetables rather than by reducing sodium, produced greater blood pressure benefits in some studies than sodium restriction alone.

A person eating a whole-food diet with adequate potassium from vegetables and legumes, adequate magnesium from unprocessed grains and leafy greens, and moderate sodium from unrefined sources is operating in a physiologically different context than a person eating processed food stripped of compensating minerals. Applying the same restriction recommendation to both without differentiating between contexts is a meaningful part of why population-level sodium restriction trials produce inconsistent results.

(Evidence level: 3 for the sodium-potassium ratio as a more predictive cardiovascular marker than sodium alone. Mechanistically well-supported, population-level intervention trials are mixed.)

Follow the Funding

The American Heart Association was established as a national institution with a $1 million gift from Procter & Gamble in 1948. P&G manufactured Crisco, a hydrogenated vegetable shortening whose commercial success required Americans to stop eating animal fats. The AHA's dietary recommendations in the decades following consistently favored replacing saturated fat with polyunsaturated vegetable oils, which directly benefited P&G and the broader vegetable oil industry.

That financial origin created an institutional framework that was not neutral on dietary fat. The sodium recommendation emerged from the same framework. The same organization that told Americans to replace butter with margarine told them to restrict sodium. Both recommendations followed from research environments with industry financial presence.

The PURE study team disclosed their funding: the Population Health Research Institute, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and national health research agencies in participating countries. No food industry funding. No pharmaceutical industry funding. The study produced findings that contradicted the established position. The institutional response was a methodological challenge, not a revision of guidelines.

This does not make PURE definitive or the established guidelines entirely wrong. What it establishes is that the research being challenged was independently funded, and the research those challenges defended was not. When evaluating which findings to weight, that distinction is part of the evidence.

---

What Is Proven, Plausible, and Unknown

Proven (Level 4-5 evidence): Sodium is an essential electrolyte required for nerve function, muscle contraction, and fluid balance (Level 5. Established physiology). The PURE study found a J-curve association between sodium excretion and cardiovascular events in 101,945 participants, with both low and high extremes showing worse outcomes than moderate intake (Level 4. NEJM 2014, biomarker-measured, non-industry funded). Sodium restriction reduces blood pressure in hypertensive individuals (Level 4. Multiple RCTs). The original low-sodium guidelines trace back to rat studies using doses 50 times the typical human intake (Level 5; documented in Dahl's own published methodology).

Plausible: mechanism documented, definitive human evidence not established (Level 2-3): The sodium-to-potassium ratio is a more meaningful dietary variable for cardiovascular outcomes than sodium intake alone for people eating whole-food diets. Chronic sodium restriction below physiological needs activates the renin-angiotensin-aldosterone system, potentially producing compensatory increases in blood pressure through a mechanism distinct from the one restriction is intended to prevent.

Unknown (Level 1-2): The optimal sodium intake range for the general population is for those eating a mixed diet of whole and processed foods. Whether the J-curve relationship in PURE generalizes to all populations or reflects specific characteristics of the 17-country study sample. The long-term cardiovascular outcomes of replacing refined table salt with unrefined mineral salt at equivalent sodium content.

---

The Risk/Reward Verdict

ATH Verdict: Worth Investigating Further

The evidence that sodium restriction below 3 grams per day protects the general healthy population from cardiovascular mortality is not established by the best available independent data. Evidence that moderate sodium intake from whole-food sources, in the range of 3 to 6 grams per day, is associated with the best cardiovascular outcomes is documented in the largest study of its kind. The evidence that unrefined mineral salt provides trace minerals absent from refined table salt is established in analytical chemistry. The actionable switch, from refined sodium chloride to unrefined mineral salt at moderate whole-food intake levels, carries essentially no downside risk and is consistent with the independent evidence base. For people with diagnosed hypertension, heart failure, or kidney disease, individual medical guidance applies.

---

What To Do Today

If you eat primarily whole foods, the PURE evidence suggests you do not need to restrict sodium below what your body naturally signals. Salt food to taste. Use unrefined mineral salt rather than refined table salt. Unrefined salts retain trace minerals, including magnesium and potassium, that refined table salt strips. Look for salt that shows mineral content on the label or comes from ancient sea beds or Himalayan deposits. Refined table salt contains sodium chloride, anti-caking agents, and iodine added back after processing. That is it.

If you eat processed food regularly, the sodium issue in your diet is not primarily about using less salt at the table. It is about the 70% of American sodium intake that comes from processed and restaurant food, delivered without the potassium and magnesium that counterbalance it in whole food. Replacing processed food with whole food addresses the sodium-to-potassium ratio more effectively than reducing added salt.

Electrolyte balance matters for anyone who exercises regularly, sweats heavily, or eats a low-carbohydrate diet. Those populations excrete sodium at higher rates. Their need for sodium from whole foods and mineral salt sources is higher than the AHA guideline addresses. Look for an electrolyte product in the ATH supplement collection that provides sodium alongside potassium and magnesium in documented ratios.

The unrefined mineral salt from verified sources in the ATH Food and Pantry collection meets the standard supported by the research.

---

Go Verify

1. Search PubMed for "O'Donnell Mente PURE sodium NEJM 2014." Read the full paper and specifically Table 3, which shows the cardiovascular event rates by sodium excretion quartile. The J-curve is visible directly in the data.

2. Search PubMed for "Adler Taylor Martin Cochrane salt cardiovascular 2014." Read the Cochrane review conclusion on whether sodium restriction reduces cardiovascular events versus blood pressure. Note what the review says is established versus what remains unclear.

3. Ask your doctor: given that the PURE study found low sodium intake below 3 grams per day is associated with higher cardiovascular mortality, why does the AHA recommendation of 2.3 grams fall in that range? What evidence would need to exist to update the recommendation?

4. Read the financial disclosure section of the most recent Dietary Guidelines Advisory Committee report. It is a public document available at dietaryguidelines.gov. Note which committee members disclosed financial relationships to food companies or pharmaceutical manufacturers and which guidelines those relationships potentially touched.

5. Look at a nutrition label on any processed food in your kitchen. Compare the sodium content to the potassium content. The sodium-to-potassium ratio in processed food versus whole food is the context in which the population-level sodium data was produced. That context shapes every study that uses dietary recall rather than biomarker measurement.

---

Sources and Citations

1. Mente A, O'Donnell MJ, Rangarajan S, et al. (PURE Investigators). "Association of urinary sodium and potassium excretion with blood pressure." New England Journal of Medicine. 2014;371(7):601-611.
2. O'Donnell M, Mente A, Rangarajan S, et al. (PURE Investigators). "Urinary sodium and potassium excretion, mortality, and cardiovascular events." New England Journal of Medicine. 2014;371(7):612-623.
3. Adler AJ, Taylor F, Martin N, et al. "Reduced dietary salt for the prevention of cardiovascular disease." Cochrane Database of Systematic Reviews. 2014;12:CD009217.
4. Dahl LK. "Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension." Journal of Experimental Medicine. 1961;114(2):231-236.
5. Intersalt Cooperative Research Group. "Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion." BMJ. 1988;297(6644):319-328.
6. Sacks FM, Svetkey LP, Vollmer WM, et al. (DASH-Sodium Collaborative Research Group). "Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension diet." New England Journal of Medicine. 2001;344(1):3-10.